gener pharma closer look teva/myl ou
expect eu/igpa confer question ask
meet investor europ today next week ahead annual medicin
europ intern gener biosimilar associ igba confer june
attend confer present third year row well particip
panel host execut gener compani includ teva confer
histor littl wall street presenc come import time given expect
ou headwind report teva grow investor focu stabil case
notabl growth expect eu region also beyond
decent amount incom call volume/focu sector week heel
sector volatil report gener pharma primer new environ
 deep dive look new gener realiti lower price target ensu report feedback
gener pharma investor feedback primer common theme question expect
eu/igba confer ensu discuss broader headlin concern
posit attain ebitda forecast remain critic think ou gener busi
get attent busi compris revenu teva
broken contribut region year recent commentari guidanc exhibit
look next week sever question look answer
see big impact serial europ teva spoke
teva indic compani prepar impact caught investor
off-guard focu whether fulli behind us compani indic
eu gener trend stabil sign price pressur across region
teva last call compani call five quarter row million gener eu revenu
part messag overal gener busi stabil hand saw
declin constant currenc consolid eu result gener profit
behind confid mid singl digit eu growth impli high singl
digit growth factor fx confid express late mid-may outlook
weight rel launch believ reflect million new launch revenu year
new launch contribut ou million split eu/row biosimilar import
driver ogivri hulio etc per prior cross-read partner biocon link expect biosimilar
focu confer also bx season dynam
risk eros japan teva per note link teva million
revenu total japan expect declin year issu stem
nation health insur price revis ii long-list product llp eros
china grow threat competitor call increas presenc china
report receiv question region india histor notabl presenc
confer look updat thought around competit move seen china
primari area perceiv opportun shift given challeng experienc us
market specif interest whether compani re-alloc spend
region away us
price prior trade day market close estimate unless otherwis note
valu eur unless otherwis note
capit market appreci consider institut investor all-america research survey
gener pharma closer look teva/myl ou
exhibit teva exposur eu row
total revenu
total revenu
full year effect over-the-counter jv dissolut
commentari advers impact japan due
price revis llp eros
japanes declin major driver weak
believ japan million
intern market japan russia israel japan
oper busi busi ventur takeda
stake takeda own remain
takeda
see stabil us gener european gener
mean see stabil global gener
busi market sequenti
due expect weak sale gener japan attribut
region weak season would expect
busi pick level later year still
sale full year guid februari
total revenu
total revenu
look maintain leadership posit market franc
itali priorit opportun addit market
germani spain
fx piec would calibr littl bit say said
year mid singl digit growth europ could
put littl bit fx headwind probabl look someth
like high singl digit year constant currenc basi mayb
quit high
estim explicitli broken
indic eu gener
eu revenu expect weight
gener pharma closer look teva/myl ou
analyst respons prepar research report receiv compens base upon variou factor includ
total revenu member compani capit market affili portion gener
invest bank activ member compani capit market affili
pleas note current conflict disclosur may differ public date set forth
report access current conflict disclosur client refer http //www rbccm com/gldisclosure/publicweb/
send request cm research publish bay street royal bank plaza
capit market llc make market secur
capit market llc make market secur teva pharmaceut industri limit
member compani capit market one affili receiv compens product servic
invest bank servic teva pharmaceut industri limit past month time member
compani capit market one affili provid non-secur servic teva pharmaceut industri limit
capit market current provid teva pharmaceut industri limit non-secur servic
explan capit market equiti rate system
analyst sector univers compani analyst provid research coverag accordingli rate assign
particular stock repres sole analyst view stock perform next month rel
top pick tp repres analyst best idea sector expect provid signific absolut total return month
favor risk-reward ratio
outperform expect materi outperform sector averag month
sector perform sp return expect line sector averag month
under-perform return expect materi sector averag month
restrict polici preclud certain type commun includ invest recommend
act advisor certain merger strateg transact certain circumst
rate nr rate price target estim remov due applic legal regulatori polici constraint
may includ capit market act advisori capac involv compani
specul risk rate reflect secur lower level financi oper predict illiquid share trade volum
high balanc sheet leverag limit oper histori result higher expect financi and/or stock price volatil
distribut rate
purpos rate distribut regulatori rule requir member firm assign rate one three rate categori
 buy hold/neutr sell regardless firm rate categori although capit market rate top pick/
outperform sector perform under-perform close correspond buy hold/neutr sell respect mean
rate determin rel basi
distribut rate
gener pharma closer look teva/myl ou
rate price target histori mylan us usd
tp top pick outperform sp sector perform under-perform restrict initi research coverag discontinu research coverag
nr rate na avail rl recommend list rl refer date secur place recommend list rl refer date
secur remov recommend list rtg rate
creat bluematrix
rate price target histori teva pharmaceut industri limit teva us usd
tp top pick outperform sp sector perform under-perform restrict initi research coverag discontinu research coverag
nr rate na avail rl recommend list rl refer date secur place recommend list rl refer date
secur remov recommend list rtg rate
creat bluematrix
refer recommend list recommend histori chart may includ one recommend list model
portfolio maintain wealth manag one affili wealth manag recommend list includ
guid portfolio prime incom rl guid portfolio dividend growth rl guid portfolio adr rl
guid portfolio cap growth rl capit market recommend list includ strategi focu list
fundament equiti weight portfolio abbrevi rl mean date secur place
recommend list abbrevi rl mean date secur remov recommend list
equiti valuat risk
valuat method use determin risk may imped achiev price target cover compani pleas
see recent company-specif research report http //www rbcinsightresearch com send request capit
gener pharma closer look teva/myl ou
price target base equal price-to-earnings ev/ebitda use target multipl near sector
low reflect concern around corpor govern impli return price target support outperform rate
risk rate price target
risk rate price target includ limit extend delay key product gener restasi
impair us base busi inopportun use cash boost leverag perpetu debt overhang
price target base equal price-to-earnings ev/ebitda reflect teva moder lower tax rate current leverag
price target base multipl respect reflect uniqu fundament risk current
environ ii uncertainti around addit gener copaxon launch iii brand pipelin without risk iv
leverag risk heighten level price target support sector perform rate
risk rate price target
follow could lead teva realiz downsid price target rate slower expect sale ramp
ajovi austedo higher expect top-lin impact base busi aggress cost cut continu price
pressur multipl addit gener copaxon launch weak cash flow gener jeopard debt paydown
coven complianc uncertainti around potenti liabil associ opioid litig
capit market polici manag conflict interest relat invest research avail us request
access current polici client refer
send request capit market research publish bay street royal bank plaza floor south
tower toronto ontario reserv right amend supplement polici time
dissemin research short-term trade idea
capit market endeavor make reason effort provid research simultan elig client
regard local time zone oversea jurisdict capit market equiti research post proprietari websit
ensur elig client receiv coverag initi chang rate target opinion time manner addit
distribut may done sale personnel via email fax electron mean regular mail client may also
receiv research via third parti vendor capit market also provid elig client access sparc firm
proprietari insight websit via email via third-parti vendor sparc contain market color commentari regard
subject compani firm current provid equiti research coverag research analyst may time time
includ short-term trade idea research report sparc short-term trade idea offer short-term view
secur may trade base market trade event result trade opportun may avail
short-term trade idea may differ price target recommend publish research report reflect
research analyst view long-term one year prospect subject compani result differ time horizon
methodolog and/or factor thu possibl subject compani common equiti consid long-term
sector perform even under-perform might present short-term buy opportun result temporari sell pressur
market convers subject compani common equiti rate long-term outperform could consid suscept
short-term downward price correct short-term trade idea rate part rate system
firm gener intend undertak oblig maintain updat short-term trade idea short-term trade
idea may suitabl investor tailor individu investor circumst object
investor make independ decis regard secur strategi discuss herein pleas contact
invest advisor institut salesperson inform regard capit market research
gener pharma closer look teva/myl ou
list recommend compani dissemin prior period pleas click
month histori sparc view http //www rbcinsightresearch com
view express report accur reflect person view respons analyst
subject secur issuer part compens respons analyst name herein directli
indirectli relat specif recommend view express respons analyst report
global industri classif standard gic develop exclus properti servic mark inc standard poor financi servic
llc licens use neither parti involv make compil gic gic classif make express impli
warranti represent respect standard classif result obtain use thereof parti herebi expressli disclaim warranti
origin accuraci complet merchant fit particular purpos respect standard classif without limit forego
event shall affili third parti involv make compil gic gic classif liabil direct indirect special
punit consequenti damag includ lost profit even notifi possibl damag
refer herein libor libo rate libor abbrevi mean london interbank offer rate administ benchmark administr
person take administr rate
capit market busi name use certain branch subsidiari royal bank canada includ dominion secur inc
capit market llc europ limit royal bank canada hong kong branch royal bank canada sydney branch inform contain
report compil capit market sourc believ reliabl represent warranti express impli made royal
canada capit market affili person accuraci complet correct opinion estim contain
report constitut capit market judgement date report subject chang without notic provid good faith without
legal respons noth report constitut legal account tax advic individu tailor invest advic materi prepar gener
circul client prepar without regard individu financi circumst object person receiv invest
servic contain report may suitabl recommend consult independ invest advisor doubt
suitabl invest servic report offer sell solicit offer buy secur past perform guid
futur perform futur return guarante loss origin capit may occur capit market research analyst compens base
part overal profit capit market includ profit attribut invest bank revenu everi provinc canada state
 countri throughout world law regul type secur invest product may offer
resid well process result secur discuss report may elig sale jurisdict
capit market may restrict publish research report time time due regulatori restrict and/ intern complianc polici
case latest publish research report avail client may reflect recent materi chang applic industri and/or applic subject
compani capit market research report current date set forth research report report circumst
constru solicit act secur broker dealer jurisdict person compani legal permit carri
busi secur broker dealer jurisdict full extent permit law neither capit market affili
person accept liabil whatsoev direct consequenti loss aris use report inform contain herein matter
contain document may reproduc copi mean without prior consent capit market
addit inform avail request
public approv capit market llc member finra nyse sipc regist broker-deal accept
respons report dissemin unit state recipi report regist broker-deal bank act
broker dealer capac wish inform regard effect transact secur discuss report
contact place order capit market llc
public approv dominion secur inc member iiroc canadian recipi report design institut
ontario accredit investor british columbia alberta sophist purchas quebec similar permit purchas provinc
wish inform regard effect transact secur discuss report contact place order
dominion secur inc without way limit forego accept respons report dissemin canada
public approv europ limit el author prudenti regul author regul
conduct author fca prudenti regul author connect distribut unit kingdom materi gener
distribut unit kingdom retail client defin rule fca rbcel accept respons report dissemin
unit kingdom
materi distribut germani europ limit frankfurt branch regul bundesanstalt fr finanzdienstleistungsaufsicht bafin
receiv advic australia
materi distribut australia royal bank canada sydney branch abn afsl materi prepar
gener circul take account object financi situat need recipi accordingli recipi act
gener pharma closer look teva/myl ou
materi consid appropri materi regard object financi situat need materi relat acquisit
possibl acquisit particular financi product recipi australia obtain relev disclosur document prepar respect product
